Clin2
NCT07785830Likely a fitNot yet recruiting

How a new drug affects a common cholesterol medicine

Healthy

Treatments studied

This study checks if a new investigational drug (MK-4646) changes how the body handles rosuvastatin, a common cholesterol-lowering medicine. It is for healthy people to see if the new drug is safe to take together.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
16 people
Ages
18 years to 60 years
Study type
Interventional

Who can take part

  • You are in generally good health.
  • Your body mass index (BMI) is between 18 and 32, which is a range from underweight to slightly overweight.
  • You have no significant medical conditions like heart, kidney, liver, or nervous system disorders.
  • You have no history of cancer.
  • You have no muscle problems or a condition called rhabdomyolysis, which can happen with some cholesterol medicines.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07743151Recruiting· Phase 1
Study of the drug MK-1406 in healthy participants

This trial is testing a new drug, MK-1406, in healthy volunteers to see how the body processes it. It helps researchers find the right dose and check for side effects before testing in patients.

Hollywood, Florida
NCT07862621Not yet recruiting· Phase 1
Testing a new drug with two common medicines

This trial tests an investigational drug called MK-6916 in healthy volunteers to see how it interacts with two common medicines (midazolam and rosuvastatin). It helps understand how the body processes these drugs together.

NCT07697625Recruiting· Phase 1
Study of MK-4082 in healthy volunteers

This trial tests a new medicine called MK-4082 in healthy people to see how safe it is and how the body handles it. It may help understand if the drug could be used for future treatments.

Anaheim, California
NCT07744386Not yet recruiting· Phase 1
How a new medicine affects blood thinner and cholesterol drug

This study tests how a new investigational medicine affects the way your body handles two common drugs: a blood thinner (dabigatran) and a cholesterol-lowering medicine (rosuvastatin). It helps researchers understand if the new medicine is safe to use together with these drugs.

Leeds
NCT07001787Not yet recruiting· Phase 1
Safety of a new cholesterol-lowering pill in healthy adults

This study tests a new oral drug (HS-10510) in healthy people to check its safety and how the body handles it. It may help lower cholesterol, and some parts of the study look at how it works in people with higher cholesterol

NCT04903223Recruiting· Phase 1
Testing how fat in the liver affects statin use in kids

This early study tests whether “liver fat” changes how a statin (rosuvastatin) works in children and teens. It may help doctors choose safer or more effective dosing in kids based on biology and a specific genetics marker.

Kansas City, Missouri

Hear when a new Healthy trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.